DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	144,405	131,049	156,349	169,609	232,556	240,580
Market Cap Growth	-21.95%	-16.18%	-7.82%	-27.07%	-3.33%	-
Enterprise Value	201,217	172,921	172,036	175,056	221,869	244,593
Last Close Price	5340.00	4800.00	5520.25	5861.21	7711.26	7735.30
PE Ratio	-	64.38	13.24	25.64	24.94	26.32
PS Ratio	0.59	0.53	0.73	0.87	1.50	1.73
PB Ratio	1.42	1.24	1.42	1.66	2.32	2.54
P/TBV Ratio	1.63	1.42	1.57	1.82	2.40	2.60
P/FCF Ratio	-	-	-	14.32	17.05	108.33
P/OCF Ratio	12.75	7.56	43.61	10.08	12.99	32.13
EV/Sales Ratio	0.83	0.69	0.80	0.90	1.43	1.76
EV/EBITDA Ratio	11.39	8.66	8.33	7.79	16.82	20.19
EV/EBIT Ratio	20.79	13.63	11.77	10.40	27.26	32.14
EV/FCF Ratio	-109.69	-	-	14.78	16.27	110.14
Debt / Equity Ratio	0.95	0.82	0.40	0.34	0.24	0.25
Debt / EBITDA Ratio	5.26	4.34	2.12	1.53	1.84	1.96
Debt / FCF Ratio	-	-	-	2.90	1.78	10.69
Asset Turnover	1.05	1.15	1.19	1.19	1.04	-
Inventory Turnover	1.98	2.20	2.26	2.74	2.52	-
Quick Ratio	0.52	0.50	0.61	0.83	0.97	1.17
Current Ratio	0.98	0.93	1.21	1.32	1.48	1.79
Return on Equity (ROE)	-2.91%	1.84%	11.11%	6.54%	9.58%	-
Return on Assets (ROA)	2.78%	3.65%	5.03%	6.44%	3.40%	-
Return on Capital (ROIC)	3.57%	4.58%	6.29%	8.07%	4.19%	-
Return on Capital Employed (ROCE)	7.60%	9.90%	12.40%	15.90%	7.80%	7.30%
Earnings Yield	-2.11%	1.55%	7.56%	3.90%	4.01%	3.80%
FCF Yield	-1.27%	-3.45%	-6.56%	6.98%	5.86%	0.92%
Payout Ratio	-	162.74%	25.72%	42.39%	10.11%	10.32%
Buyback Yield / Dilution	1.55%	1.13%	0.48%	1.78%	0.12%	-25.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.